BIO-Europe, the must-attend global biopharma strategy forum, today publishes its inaugural Biopharma C-Suite Agenda Survey 2026, providing a timely, data-led view of how senior industry leaders are navigating a period of renewed dealmaking appetite, persistent capital pressure and shifting global competition.